← Leaderboards
Patricia A. Murphy
Columbia University Health Sciences
$1,116,612
Attributed
$1,116,612
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $224.3K · FY2005–06$250K$187.5K$125K$62.5K$0
'05
'06
Funding mix
By agency
NIH$1,116,612 · 4
By mechanism
R21$848,884 · 2
P50$250,232 · 1
M01$17,496 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Richard W Foltin$21,307,956
- Carolyn L Westhoff$8,326,369
- Marian W Fischman$5,515,675
- Diana M Martinez$12,679,324
- Wafaa M. El-Sadr$1,113,559,119
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectFemaleAlternative MedicineClinical ResearchWomen'S HealthAgingBiomedical FacilityData ManagementMedical Outreach /Case FindingYoung Adult Human (21-34)Medicinal PlantsDrug InteractionsOral ContraceptivesCytochrome P450Graafian FolliclesClinical TrialsImmunofluorescence TechniqueLuteinizing HormoneMenstrual CycleNorethindroneDrug Adverse EffectDrug MetabolismEnzyme ActivityEthinyl Estradiol
Grant awards (10)
St. John's Wort Effects on Levonorgestrel$218,980
R21 · FY2006 · AT · contact PI
St. John's Wort Effects on Levonorgestrel$224,250
R21 · FY2005 · AT
Saint John's Wort$17,496
M01 · FY2004 · RR
Effects of Hypericum Perforatum on Oral Contraceptives$204,375
R21 · FY2002 · AT
Core--Clinical Research Facility$0
P50 · FY2002 · AT
Effects of Hypericum Perforatum on Oral Contraceptives$201,279
R21 · FY2001 · AT
Core--Clinical Research Facility$0
P50 · FY2001 · AT
Core--Clinical Research Facility$0
P50 · FY2001 · AT
Core--Clinical Research Facility$0
P50 · FY2001 · AT
Core--Clinical Research Facility$250,232
P50 · FY2000 · AT